Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines

Virology

Volumn 258, Issue 2, 1999, Pages 375-381

  Gao, Xiangrong ^a   Tajima, Masako ^b   Sairenji, Takeshi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STOMACH EPITHELIUM; TRANSACTIVATION; VIRUS LATENCY; VIRUS REACTIVATION;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0033526529     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9748     Document Type: Article

References (40)

1. Akarid K., Sinet M., Desforges B., Gougerot Pocidalo M. A. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 69:1995;7001-7005.
2. Bredt D. S., Snyder S. H. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63:1994;175-195.
3. Chevallier Greco A., Manet E., Chavrier P., Mosnier C., Daillie J., Sergeant A. Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 5:1986;3243-3249.
4. Countryman J., Miller G. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA. 82:1985;4085-4089.
5. Croen K. D. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:1993;2446-2452.
6. Flemington E., Speck S. H. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1990;1227-1232.
7. Flesch I. E., Hess J. H., Oswald I. P., Kaufmann S. H. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: Regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int. Immunol. 6:1994;693-700.
8. Gilad E., Zingarelli B., Salzman A. L., Szabo C. Protection by inhibition of poly (ADP-ribose) synthetase against oxidant injury in cardiac myoblasts in vitro. J. Mol. Cell. Cardiol. 29:1997;2585-2597.
9. Granger D. L. Macrophage production of nitrogen oxides in host defence against microorganisms. Res. Immunol. 142:1991;570-572.
10. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
11. Harris N., Buller R. M., Karupiah G. Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J. Virol. 69:1995;910-915.
12. Hojo H. Establishment of cultured cell line of human stomach cancer origin and their morphogical characteristics. Nigata Igaku Zasshi. 91:1977;737-752.
13. Iwasaki Y., Chong J., Hayshi Y., Ikeno R., Arai K., Kitamura M., Koike M., Hirai K., Fukayama M. Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice. J. Virol. 72:1998;8321-8326.
14. Karupiah G., Xie Q. W., Buller R. M., Nathan C., Duarte C., MacMicking J. D. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science. 261:1993;1445-1448.
15. Kawanishi M. Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV. Intervirology. 38:1995;206-213.
16. Mannick J. B., Asano K., Izumi K., Kieff E., Stamler J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
17. Mellinghoff I., Daibata M., Humphreys R. E., Mulder C., Takada K., Sairenji T. Early events in Epstein-Barr virus genome expression after activation: Regulation by second messengers of B cell activation. Virology. 185:1991;922-928.
18. Miller G., Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 70:1973;190-194.
19. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
20. Nakamura L. T., Wu Hsieh B. A., Howard D. H. Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect. Immunol. 62:1994;680-684.
21. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
22. Nathan C. F., Hibbs J. B. Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:1991;65-70.
23. Nathan C., Xie Q. W. Nitric oxide synthases: Roles, tolls, and controls. Cell. 78:1994;915-918.
24. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature. 333:1988;664-666.
25. Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma [see comments]. N. Engl. J. Med. 333:1995;693-698.
26. Pope M., Marsden P. A., Cole E., Sloan S., Fung L. S., Ning Q., Ding J. W., Leibowitz J. L., Phillips M. J., Levy G. A. Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide. J. Virol. 72:1998;7084-7090.
27. Rickinson A. B., Lee S. P., Steven N. M. Cytotoxic T lymphocyte responses to Epstein-Barr virus. Curr. Opin. Immunol. 8:1996;492-497.
28. Sandau K., Brune B. The dual role of S-nitrosoglutathione (GSNO) during thymocyte apoptosis. Cell Signal. 8:1996;173-177.
29. Shastry B. S., Trese M. T. Identification of a polymorphic missense (G338D) and silent (106V and 121L) mutations within the coding region of the peripherin/RDS gene in a patient with retinitis punctata albescens. Biochem. Biophys. Res. Commun. 231:1997;103-105.
30. Stenger S., Thuring H., Rollinghoff M., Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:1994;783-793.
31. Stuehr D. J., Marletta M. A. Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 82:1985;7738-7742.
32. Tajima M., Komuro M., Okinaga K. Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn. J. Cancer Res. 89:1998;262-268.
33. Takada K. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer. 33:1984;27-32.
34. Takada K., Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:1989;445-449.
35. Takada K., Shimizu N., Sakuma S., Ono Y. Trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J. Virol. 57:1986;1016-1022.
36. Takasaka N., Tajima M., Okinaga K., Satoh Y., Hoshikawa Y., Kasumoto T., Kurata T., Sairenji T. Productive infection of Epstein-Barr virus in EBV-genome-positive epithelia cell lines (GT38 and GT39) derived from gastric tissues. Virology. 247:1998;152-159.
37. Wang H., Gao X., Fukumoto S., Tademoto S., Sato K., Hirai K. Post-isolation inducible nitric oxide synthase gene expression due to collagenase buffer perfusion and characterization of the gene regulation in primary cultured murine hepatocytes1. J. Biochem. 124:1998;892-899.
38. Wang J. H., Ko G. Y., Kelly P. T. Cellular and molecular bases of memory: synaptic and neuronal plasticity. J. Clin. Neurophysiol. 14:1997;264-293.
39. Yun H. Y., Dawson V. L., Dawson T. M. Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10:1996;291-316.
40. zur Hausen H. Persisting oncogenic herpesvirus induced by tumour promoter TPA. Nature. 272:1978;373-375.